
Keywords: SAR; structure-activity relationship; ACT; artemisinin combination therapy; HPLC; high performance liquid chromatography; DMAP; 4-dimethylaminopyridine; Py; pyridine; Antimalarial chemotherapy; Trioxane dimers; Single oral dose ACT; Oral bioavailability